1 Human Immunoglobulin Market Overview 1.1 Product Overview and Scope of Human Immunoglobulin 1.2 Human Immunoglobulin Segment by Type 1.2.1 Global Human Immunoglobulin Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Intramuscular Injection 1.2.3 Intravenous Injection 1.3 Human Immunoglobulin Segment by Application 1.3.1 Global Human Immunoglobulin Sales Comparison by Application: (2022-2028) 1.3.2 Disease Prevention 1.3.3 Treatment 1.3.4 Diagnosis 1.3.5 Other 1.4 Global Human Immunoglobulin Market Size Estimates and Forecasts 1.4.1 Global Human Immunoglobulin Revenue 2017-2028 1.4.2 Global Human Immunoglobulin Sales 2017-2028 1.4.3 Human Immunoglobulin Market Size by Region: 2017 Versus 2021 Versus 2028 2 Human Immunoglobulin Market Competition by Manufacturers 2.1 Global Human Immunoglobulin Sales Market Share by Manufacturers (2017-2022) 2.2 Global Human Immunoglobulin Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Human Immunoglobulin Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Human Immunoglobulin Manufacturing Sites, Area Served, Product Type 2.5 Human Immunoglobulin Market Competitive Situation and Trends 2.5.1 Human Immunoglobulin Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Human Immunoglobulin Players Market Share by Revenue 2.5.3 Global Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Human Immunoglobulin Retrospective Market Scenario by Region 3.1 Global Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Human Immunoglobulin Market Facts & Figures by Country 3.3.1 North America Human Immunoglobulin Sales by Country 3.3.2 North America Human Immunoglobulin Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Human Immunoglobulin Market Facts & Figures by Country 3.4.1 Europe Human Immunoglobulin Sales by Country 3.4.2 Europe Human Immunoglobulin Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Human Immunoglobulin Market Facts & Figures by Region 3.5.1 Asia Pacific Human Immunoglobulin Sales by Region 3.5.2 Asia Pacific Human Immunoglobulin Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Human Immunoglobulin Market Facts & Figures by Country 3.6.1 Latin America Human Immunoglobulin Sales by Country 3.6.2 Latin America Human Immunoglobulin Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Human Immunoglobulin Market Facts & Figures by Country 3.7.1 Middle East and Africa Human Immunoglobulin Sales by Country 3.7.2 Middle East and Africa Human Immunoglobulin Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Human Immunoglobulin Historic Market Analysis by Type 4.1 Global Human Immunoglobulin Sales Market Share by Type (2017-2022) 4.2 Global Human Immunoglobulin Revenue Market Share by Type (2017-2022) 4.3 Global Human Immunoglobulin Price by Type (2017-2022) 5 Global Human Immunoglobulin Historic Market Analysis by Application 5.1 Global Human Immunoglobulin Sales Market Share by Application (2017-2022) 5.2 Global Human Immunoglobulin Revenue Market Share by Application (2017-2022) 5.3 Global Human Immunoglobulin Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Takeda 6.1.1 Takeda Corporation Information 6.1.2 Takeda Description and Business Overview 6.1.3 Takeda Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Takeda Human Immunoglobulin Product Portfolio 6.1.5 Takeda Recent Developments/Updates 6.2 CSL 6.2.1 CSL Corporation Information 6.2.2 CSL Description and Business Overview 6.2.3 CSL Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.2.4 CSL Human Immunoglobulin Product Portfolio 6.2.5 CSL Recent Developments/Updates 6.3 Grifols 6.3.1 Grifols Corporation Information 6.3.2 Grifols Description and Business Overview 6.3.3 Grifols Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Grifols Human Immunoglobulin Product Portfolio 6.3.5 Grifols Recent Developments/Updates 6.4 Octapharma 6.4.1 Octapharma Corporation Information 6.4.2 Octapharma Description and Business Overview 6.4.3 Octapharma Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Octapharma Human Immunoglobulin Product Portfolio 6.4.5 Octapharma Recent Developments/Updates 6.5 Biotest 6.5.1 Biotest Corporation Information 6.5.2 Biotest Description and Business Overview 6.5.3 Biotest Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Biotest Human Immunoglobulin Product Portfolio 6.5.5 Biotest Recent Developments/Updates 6.6 China National Pharmaceutical Group Corporation 6.6.1 China National Pharmaceutical Group Corporation Corporation Information 6.6.2 China National Pharmaceutical Group Corporation Description and Business Overview 6.6.3 China National Pharmaceutical Group Corporation Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.6.4 China National Pharmaceutical Group Corporation Human Immunoglobulin Product Portfolio 6.6.5 China National Pharmaceutical Group Corporation Recent Developments/Updates 6.7 CTBB 6.6.1 CTBB Corporation Information 6.6.2 CTBB Description and Business Overview 6.6.3 CTBB Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.4.4 CTBB Human Immunoglobulin Product Portfolio 6.7.5 CTBB Recent Developments/Updates 6.8 Hualan Bio 6.8.1 Hualan Bio Corporation Information 6.8.2 Hualan Bio Description and Business Overview 6.8.3 Hualan Bio Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Hualan Bio Human Immunoglobulin Product Portfolio 6.8.5 Hualan Bio Recent Developments/Updates 6.9 RASS 6.9.1 RASS Corporation Information 6.9.2 RASS Description and Business Overview 6.9.3 RASS Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.9.4 RASS Human Immunoglobulin Product Portfolio 6.9.5 RASS Recent Developments/Updates 6.10 Shanxi Kangbao Biological Product 6.10.1 Shanxi Kangbao Biological Product Corporation Information 6.10.2 Shanxi Kangbao Biological Product Description and Business Overview 6.10.3 Shanxi Kangbao Biological Product Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Shanxi Kangbao Biological Product Human Immunoglobulin Product Portfolio 6.10.5 Shanxi Kangbao Biological Product Recent Developments/Updates 6.11 Shuanglin Bio Pharma 6.11.1 Shuanglin Bio Pharma Corporation Information 6.11.2 Shuanglin Bio Pharma Human Immunoglobulin Description and Business Overview 6.11.3 Shuanglin Bio Pharma Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Shuanglin Bio Pharma Human Immunoglobulin Product Portfolio 6.11.5 Shuanglin Bio Pharma Recent Developments/Updates 6.12 Sichuan Yuanda Shuyang Pharmaceutical 6.12.1 Sichuan Yuanda Shuyang Pharmaceutical Corporation Information 6.12.2 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Description and Business Overview 6.12.3 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Product Portfolio 6.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates 7 Human Immunoglobulin Manufacturing Cost Analysis 7.1 Human Immunoglobulin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Human Immunoglobulin 7.4 Human Immunoglobulin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Human Immunoglobulin Distributors List 8.3 Human Immunoglobulin Customers 9 Human Immunoglobulin Market Dynamics 9.1 Human Immunoglobulin Industry Trends 9.2 Human Immunoglobulin Market Drivers 9.3 Human Immunoglobulin Market Challenges 9.4 Human Immunoglobulin Market Restraints 10 Global Market Forecast 10.1 Human Immunoglobulin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Human Immunoglobulin by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Human Immunoglobulin by Type (2023-2028) 10.2 Human Immunoglobulin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Human Immunoglobulin by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Human Immunoglobulin by Application (2023-2028) 10.3 Human Immunoglobulin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Human Immunoglobulin by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Human Immunoglobulin by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Human Immunoglobulin Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million) Table 2. Global Human Immunoglobulin Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million) Table 3. Global Human Immunoglobulin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Human Immunoglobulin Market Competitive Situation by Manufacturers in 2021 Table 5. Global Human Immunoglobulin Sales (KG) of Key Manufacturers (2017-2022) Table 6. Global Human Immunoglobulin Sales Market Share by Manufacturers (2017-2022) Table 7. Global Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Human Immunoglobulin Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Human Immunoglobulin Average Price (USD/Kg) of Key Manufacturers (2017-2022) Table 10. Manufacturers Human Immunoglobulin Manufacturing Sites and Area Served Table 11. Manufacturers Human Immunoglobulin Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunoglobulin as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Human Immunoglobulin Sales by Region (2017-2022) & (KG) Table 16. Global Human Immunoglobulin Sales Market Share by Region (2017-2022) Table 17. Global Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Human Immunoglobulin Revenue Market Share by Region (2017-2022) Table 19. North America Human Immunoglobulin Sales by Country (2017-2022) & (KG) Table 20. North America Human Immunoglobulin Sales Market Share by Country (2017-2022) Table 21. North America Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Human Immunoglobulin Revenue Market Share by Country (2017-2022) Table 23. Europe Human Immunoglobulin Sales by Country (2017-2022) & (KG) Table 24. Europe Human Immunoglobulin Sales Market Share by Country (2017-2022) Table 25. Europe Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Human Immunoglobulin Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Human Immunoglobulin Sales by Region (2017-2022) & (KG) Table 28. Asia Pacific Human Immunoglobulin Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Human Immunoglobulin Revenue Market Share by Region (2017-2022) Table 31. Latin America Human Immunoglobulin Sales by Country (2017-2022) & (KG) Table 32. Latin America Human Immunoglobulin Sales Market Share by Country (2017-2022) Table 33. Latin America Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Human Immunoglobulin Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Human Immunoglobulin Sales by Country (2017-2022) & (KG) Table 36. Middle East and Africa Human Immunoglobulin Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Human Immunoglobulin Revenue Market Share by Country (2017-2022) Table 39. Global Human Immunoglobulin Sales by Type (2017-2022) & (KG) Table 40. Global Human Immunoglobulin Sales Market Share by Type (2017-2022) Table 41. Global Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Human Immunoglobulin Revenue Share by Type (2017-2022) Table 43. Global Human Immunoglobulin Price by Type (2017-2022) & (USD/Kg) Table 44. Global Human Immunoglobulin Sales (KG) by Application (2017-2022) Table 45. Global Human Immunoglobulin Sales Market Share by Application (2017-2022) Table 46. Global Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Human Immunoglobulin Revenue Share by Application (2017-2022) Table 48. Global Human Immunoglobulin Price by Application (2017-2022) & (USD/Kg) Table 49. Takeda Corporation Information Table 50. Takeda Description and Business Overview Table 51. Takeda Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 52. Takeda Human Immunoglobulin Product Table 53. Takeda Recent Developments/Updates Table 54. CSL Corporation Information Table 55. CSL Description and Business Overview Table 56. CSL Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 57. CSL Human Immunoglobulin Product Table 58. CSL Recent Developments/Updates Table 59. Grifols Corporation Information Table 60. Grifols Description and Business Overview Table 61. Grifols Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 62. Grifols Human Immunoglobulin Product Table 63. Grifols Recent Developments/Updates Table 64. Octapharma Corporation Information Table 65. Octapharma Description and Business Overview Table 66. Octapharma Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 67. Octapharma Human Immunoglobulin Product Table 68. Octapharma Recent Developments/Updates Table 69. Biotest Corporation Information Table 70. Biotest Description and Business Overview Table 71. Biotest Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 72. Biotest Human Immunoglobulin Product Table 73. Biotest Recent Developments/Updates Table 74. China National Pharmaceutical Group Corporation Corporation Information Table 75. China National Pharmaceutical Group Corporation Description and Business Overview Table 76. China National Pharmaceutical Group Corporation Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 77. China National Pharmaceutical Group Corporation Human Immunoglobulin Product Table 78. China National Pharmaceutical Group Corporation Recent Developments/Updates Table 79. CTBB Corporation Information Table 80. CTBB Description and Business Overview Table 81. CTBB Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 82. CTBB Human Immunoglobulin Product Table 83. CTBB Recent Developments/Updates Table 84. Hualan Bio Corporation Information Table 85. Hualan Bio Description and Business Overview Table 86. Hualan Bio Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 87. Hualan Bio Human Immunoglobulin Product Table 88. Hualan Bio Recent Developments/Updates Table 89. RASS Corporation Information Table 90. RASS Description and Business Overview Table 91. RASS Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 92. RASS Human Immunoglobulin Product Table 93. RASS Recent Developments/Updates Table 94. Shanxi Kangbao Biological Product Corporation Information Table 95. Shanxi Kangbao Biological Product Description and Business Overview Table 96. Shanxi Kangbao Biological Product Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 97. Shanxi Kangbao Biological Product Human Immunoglobulin Product Table 98. Shanxi Kangbao Biological Product Recent Developments/Updates Table 99. Shuanglin Bio Pharma Corporation Information Table 100. Shuanglin Bio Pharma Description and Business Overview Table 101. Shuanglin Bio Pharma Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 102. Shuanglin Bio Pharma Human Immunoglobulin Product Table 103. Shuanglin Bio Pharma Recent Developments/Updates Table 104. Sichuan Yuanda Shuyang Pharmaceutical Corporation Information Table 105. Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview Table 106. Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Sales (KG), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 107. Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Product Table 108. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments/Updates Table 109. Production Base and Market Concentration Rate of Raw Material Table 110. Key Suppliers of Raw Materials Table 111. Human Immunoglobulin Distributors List Table 112. Human Immunoglobulin Customers List Table 113. Human Immunoglobulin Market Trends Table 114. Human Immunoglobulin Market Drivers Table 115. Human Immunoglobulin Market Challenges Table 116. Human Immunoglobulin Market Restraints Table 117. Global Human Immunoglobulin Sales Forecast by Type (2023-2028) & (KG) Table 118. Global Human Immunoglobulin Sales Market Share Forecast by Type (2023-2028) Table 119. Global Human Immunoglobulin Revenue Forecast by Type (2023-2028) & (US$ Million) Table 120. Global Human Immunoglobulin Revenue Market Share Forecast by Type (2023-2028) Table 121. Global Human Immunoglobulin Sales Forecast by Application (2023-2028) & (KG) Table 122. Global Human Immunoglobulin Sales Market Share Forecast by Application (2023-2028) Table 123. Global Human Immunoglobulin Revenue Forecast by Application (2023-2028) & (US$ Million) Table 124. Global Human Immunoglobulin Revenue Market Share Forecast by Application (2023-2028) Table 125. Global Human Immunoglobulin Sales Forecast by Region (2023-2028) & (KG) Table 126. Global Human Immunoglobulin Sales Market Share Forecast by Region (2023-2028) Table 127. Global Human Immunoglobulin Revenue Forecast by Region (2023-2028) & (US$ Million) Table 128. Global Human Immunoglobulin Revenue Market Share Forecast by Region (2023-2028) Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human Immunoglobulin Figure 2. Global Human Immunoglobulin Market Share by Type in 2021 & 2028 Figure 3. Intramuscular Injection Product Picture Figure 4. Intravenous Injection Product Picture Figure 5. Global Human Immunoglobulin Market Share by Application in 2021 & 2028 Figure 6. Disease Prevention Figure 7. Treatment Figure 8. Diagnosis Figure 9. Other Figure 10. Global Human Immunoglobulin Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Human Immunoglobulin Market Size (2017-2028) & (US$ Million) Figure 12. Global Human Immunoglobulin Sales (2017-2028) & (KG) Figure 13. Human Immunoglobulin Sales Share by Manufacturers in 2021 Figure 14. Global Human Immunoglobulin Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Human Immunoglobulin Players: Market Share by Revenue in 2021 Figure 16. Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Human Immunoglobulin Sales Market Share by Region (2017-2022) Figure 18. Global Human Immunoglobulin Sales Market Share by Region in 2021 Figure 19. Global Human Immunoglobulin Revenue Market Share by Region (2017-2022) Figure 20. Global Human Immunoglobulin Revenue Market Share by Region in 2021 Figure 21. U.S. Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. U.A.E Human Immunoglobulin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Human Immunoglobulin by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Human Immunoglobulin Figure 47. Manufacturing Process Analysis of Human Immunoglobulin Figure 48. Human Immunoglobulin Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Takeda CSL Grifols Octapharma Biotest China National Pharmaceutical Group Corporation CTBB Hualan Bio RASS Shanxi Kangbao Biological Product Shuanglin Bio Pharma Sichuan Yuanda Shuyang Pharmaceutical